Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Pennsylvania College of Optometry |
---|---|
Information provided by: | Pennsylvania College of Optometry |
ClinicalTrials.gov Identifier: | NCT00347581 |
This study is designed to compare the use of special prism glasses to placebo treatment for children with symptomatic convergence insufficiency.
Condition | Intervention | Phase |
---|---|---|
Convergence Insufficiency |
Procedure: Base-in prism glasses for reading Procedure: Placebo reading glasses |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Randomized Clinical Trial of the Effectiveness of Base-in Prism Reading Glasses Vs. Placebo Reading Glasses for Symptomatic Convergence Insufficiency in Children |
Estimated Enrollment: | 72 |
Study Start Date: | May 2003 |
Estimated Study Completion Date: | August 2004 |
The Base-in for Convergence Insufficiency Treatment Trial (BI-CITT) is a multi-center, placebo-controlled, masked, clinical trial designed to compare the benefits of base-in prism for patients with convergence insufficiency (CI).
The goals of this clinical trial are:
Ages Eligible for Study: | 9 Years to 18 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Alabama | |
University of Alabama, Birmingham, College of Optometry | |
Birmingham, Alabama, United States, 35294 | |
United States, California | |
Southern California College of Optometry | |
Fullerton, California, United States, 92831 | |
United States, Florida | |
NOVA College of Optometry | |
Ft. Lauderdale, Florida, United States, 33328 | |
Bascom Palmer Eye Institute | |
Miami, Florida, United States, 33136 | |
United States, Indiana | |
Indiana University College of Optometry | |
Bloomington, Indiana, United States, 47405 | |
United States, New York | |
State University of New York, College of Optometry | |
New York, New York, United States, 10036 | |
United States, Ohio | |
The Ohio State University | |
Columbus, Ohio, United States, 43210 | |
The Ohio State University, Optometry Coordinating Center | |
Columbus, Ohio, United States, 43210 | |
United States, Pennsylvania | |
Eye Institute, Pennsylvania College of Optometry | |
Philadelphia, Pennsylvania, United States, 19141 | |
United States, Texas | |
University of Houston, College of Optometry | |
Houston, Texas, United States, 77204 |
Study Chair: | Mitchell Scheiman, OD | Pennsylvania College of Optometry |
Study ID Numbers: | hms0304 |
Study First Received: | July 3, 2006 |
Last Updated: | July 3, 2006 |
ClinicalTrials.gov Identifier: | NCT00347581 |
Health Authority: | United States: Institutional Review Board |
convergence insufficiency base-in prism orthoptics vision therapy |
Ocular Motility Disorders Methamphetamine Motor neuro-ophthalmic disorders Dopamine |
Eye Diseases Central Nervous System Diseases Amphetamine Ocular motility disorders |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Adrenergic Agents Molecular Mechanisms of Pharmacological Action Adrenergic Uptake Inhibitors Sympathomimetics Nervous System Diseases Physiological Effects of Drugs |
Central Nervous System Stimulants Pharmacologic Actions Autonomic Agents Therapeutic Uses Dopamine Agents Cranial Nerve Diseases Peripheral Nervous System Agents Central Nervous System Agents |